Pain 101 Q&A

Pain 101 Q&A published on August 15, 2008 in Assess & Monitor
Drs. Heit and Gourlay answer questions from the audience regarding benzodiazepine withdrawal and abuse potential of fentanyl transdermal patches.
Pain 101 Q&A published on July 18, 2008 in Misuse
Dr. Gourlay answers questions regarding third-party information, interpreting urine drug test results, and setting boundaries for the prescription of controlled substances.
Pain 101 Q&A published on June 20, 2008 in Assess & Monitor
Dr. Heit responds to questions on 'Do Not Fill' regulations, detoxification vs. tapering, and sequential prescriptions. He also discusses Schedule II prescribing regulations and documentation.
Pain 101 Q&A published on May 16, 2008 in Assess & Monitor
Dr. Stanos discusses a comprehensive program for pain management that emphasizes activity, strength, and educating patients about biofeedback.
Pain 101 Q&A published on April 21, 2008 in Assess & Monitor
Dr. Ginsberg addresses the effects of methadone on the heart, the role of pharmacists in pain management, and mortality associated with pharmacotherapy.
Pain 101 Q&A published on March 31, 2008 in Assess & Monitor
Dr. Compton answers complex questions about chronic opioid therapy and other pain and addiction management issues based on neurobiologic evidence.
Pain 101 Q&A published on February 21, 2008 in Misuse

Results 1 - 7 of 7